Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21
Suvannasankha, A., Fausel, C., Juliar, B. E., Yiannoutsos, C. T., Fisher, W. B., Ansari, R. H., Wood, L. L., Smith, G. G., Cripe, L. D., Abonour, R.Volume:
12
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.12-1-99
Date:
January, 2007
File:
PDF, 101 KB
english, 2007